Squarepoint’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Buy |
77,459
+35,051
| +83% | +$128K | ﹤0.01% | 2196 |
|
|
2025
Q1 | $183K | Sell |
42,408
-84,383
| -67% | -$365K | ﹤0.01% | 2387 |
|
|
2024
Q4 | $406K | Buy |
126,791
+44,051
| +53% | +$141K | ﹤0.01% | 2051 |
|
|
2024
Q3 | $237K | Sell |
82,740
-8,294
| -9% | -$23.7K | ﹤0.01% | 2106 |
|
|
2024
Q2 | $255K | Buy |
91,034
+40,710
| +81% | +$114K | ﹤0.01% | 2034 |
|
|
2024
Q1 | $143K | Sell |
50,324
-46,018
| -48% | -$131K | ﹤0.01% | 2184 |
|
|
2023
Q4 | $394K | Buy |
96,342
+82,210
| +582% | +$336K | ﹤0.01% | 1831 |
|
|
2023
Q3 | $44.9K | Sell |
14,132
-78,968
| -85% | -$251K | ﹤0.01% | 2336 |
|
|
2023
Q2 | $309K | Buy |
93,100
+34,174
| +58% | +$113K | ﹤0.01% | 1852 |
|
|
2023
Q1 | $126K | Buy |
58,926
+40,958
| +228% | +$87.2K | ﹤0.01% | 1988 |
|
|
2022
Q4 | $48.3K | Sell |
17,968
-38,824
| -68% | -$104K | ﹤0.01% | 2149 |
|
|
2022
Q3 | $184K | Buy |
+56,792
| New | +$184K | ﹤0.01% | 1807 |
|
|
2021
Q3 | – | Sell |
-37,322
| Closed | -$620K | – | 2604 |
|
|
2021
Q2 | $620K | Sell |
37,322
-23,595
| -39% | -$392K | ﹤0.01% | 1483 |
|
|
2021
Q1 | $1.11M | Buy |
+60,917
| New | +$1.11M | 0.01% | 1010 |
|
|
2020
Q4 | – | Sell |
-67,502
| Closed | -$259K | – | 2783 |
|
|
2020
Q3 | $259K | Buy |
67,502
+46,883
| +227% | +$180K | ﹤0.01% | 1789 |
|
|
2020
Q2 | $79K | Sell |
20,619
-60,087
| -74% | -$230K | ﹤0.01% | 1977 |
|
|
2020
Q1 | $261K | Buy |
80,706
+19,163
| +31% | +$62K | 0.01% | 1355 |
|
|
2019
Q4 | $296K | Buy |
+61,543
| New | +$296K | ﹤0.01% | 1976 |
|